Centralized Chemopreventive Agent Repository and Chemistry Support   3

Background
The Division of Cancer Prevention (DCP), NCI, has a long-standing pharmaceutical agent development program administered through the Chemopreventive Agent Development and Research Group (CADRG) as a Repository services unit. The object of the Repository program is to establish a centralized source of agents for use in studies by the DCP and to support the translation of promising laboratory discoveries into effective interventions for the prevention or reduction of cancer.

Work Details
The purpose of this procurement is to continue the well-established Repository program that currently exists within the Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI). The successful Contractor shall maintain a centralized source of agents and development services necessary to support chemoprevention studies for effective medical interventions in the prevention or reduction of cancer. The repository provides important logistic organization for the acquisition, tracking, storage, maintenance, testing, quality control, and distribution of investigational agents.
The NCI intends to award one Indefinite Delivery/Indefinite Quantity (IDIQ) type contract as well as one cost plus fixed fee initial Task Order on or about July 1, 2023.

Period of Performance
The period of performance for the IDIQ contract is five years; the initial Task Order is a one-year base period plus four one-year option years.

Place of Performance
The place of performance will be the Contractor’s work site.